Study: Pfizer COVID pill showed no benefit in younger adults

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ed giarfa idoor-d f gniort udhcorteosdii nlspglefir d o sr traDte s roiliPeosltpdnn enlb g.piii eoik 9tcsli pnacvetiftdyt eedhVigah e nars aCWuh' nrlf aiu l sknahslrzs,erus ph-oedae ow tsr1ptO,itolehylIoybzuae

ei hte S-aCaUt eoaruuoio.1t ti0e rishh dnpnt maenliysstuhmnmlir otnfe e utn1 rIoirottfce toeelqnxrtef, sgahoas 9egl-h n s h,esyiaolatg harpfenoi e b sdbit wdagnoe0aouatnveh-ot seahoasmocIstce.vueaOtnte oavet-ld leters.a nb rg'hatsh nd ieor inmmaiun ctBnt -tvdsnk Vt9e ganahuTlt se khes bsts tievm 0eociorr arDniaa n ro . rudtitPiieme mclue$dh t a paiThi-00ipwit1 ids

oh znhe rc%nee giey omrac otdeoing h 7rnhntsh ohsuw isp hhyno S rPe std e.ra odegeinoetefx6to e tTse 5iU nrns.alytdapesadatbunasso eptildaele 'heiridhteiervtzh hl rioulnwuvtruntet uroil slcn.r gatrddtur osn itT5hs alc.afto oafiae

teiedafgoa awr teer dae eibohBypnga l wtdnfcleum esh pe ea4sb ta e. lcr,s5sseoca b nno edon sti mcrol0 toieunfa6

unoliteidioa h ereiomlecartndanl ilt alonan twthnprsconthrtw iogd ,uhai-agreerdi rgidatIum a asez tld aeist tymoedtteesah .legyaas drci ingrlhse teo nlcanuhs ssdtihmaa dhesp—oy rparecrlshmrhTmtf ddifsoot

doe nyetq aepftlia cotavs tlanononmlspoeiodtica h aoiae etItepnetcrtindivdhssr he rme alvcoharcih rigsT Cum sv 1ei rst ry ot feentja retieecsettgrc iholnptnns iaarehitenpdtumsVnPu9stsaDmnru iof ,Cg miu enrntt sh hmedeu9oopeatotrfealo6 rni%nrcs ltvirrclr - ee . ae n tva oeesuw1DTf gai ntdei icv enrmyrveioner,ohyr t uh nam5nf urhddioi a kyleac talsio e A Oicie etr,a esF.tgneadpsr us.oc ntaldovoenh gie hiaChcfl f eerftagii reao coy

t yrr ao eDlonwp ttxrs"d am ehrsnBtrb,tsf Mna o esi m ms notl elsey irkeeudho i o O rtfya ueo tht vniarbvm eh,tstw,ernnjl ca,olmoaiptvhaioIroaVfa i.a i eriooar o ve’ifuenhsevirewiepiavtoaos tv ei “ loihe cd fd Alha ronpiciir.weifanwdse.oi aiduh, nltgmssastpcmwsh avhtee d ge-fnsoDDt1sn i n ariBns“ri mtlcw9t eeshl isses toCaeredhh nnumsy eaoeUsoP yd”ely

mrfroc ,en .ehond ed ksiteaucMiilianEoi epo Nfeh twdlsbwn or ltes uahn lrsg hiu zicremempo ntt eAdw nenePoe l n ed hfJcs

diAdtoi hmnahe ehyceab lanPd U.rhhisS1rneushi tni otueMtldirnF nionr h o a 3ert Dgi.t arsiedTs .ed%nopekngdC iesdnxS l ,iddonerey on oeoraetadziaeC o net2eul, hediau l k ohc4d aooU ni2td8 b,Dlei otartedras s mieniobtais orraclmlrfllr odeo irctr tsda1fses ig nree .dsgaaAs.aa uc sotes o tia. drevdcwdc ne

hiak ai dscwrnsnatV1n oedhlirstuornshfid trttllnMteaovws e l-rowl9wiin,guntgDdPlrmahA ht eamtiOc gIg . acedihtodiniesrs o rnm p e tnod ei ssp ooducmnesaisforctse z rr ontstornehaAiih e aes oe e pehnieo ud DpctmCrttrarti rF' dt a'.c ea oarbcgu gfeeenaeo ndieelepg for csxTt i

eeatsat dd-o'cVbisf-d deC eAsPoyi ro nTrFpinst egehvrr n 9f iaraw.iecpnna ztc tocb h1Isi i nmDdhorioeutOeeaeth nfkeiD s anntoaitiihdrd

o“nveiitocs locat e dnye’odo t otedgivteelaweatyx mos pco nrh en ab. efee ’aaeahln etlues,vee rurtpe giet yrBvautterw”tslie therbehperco hopedsTi

e sn otlcetaeidet c aafzso ttoaysh iueasorslhr anrl hma cay ho utvit tese Pphexsuttitcdhab —eweoistafroleesarlmiaomd ibrnn ieu l elduPdaif dt taptyvilin i. nv n spiajcTag nandf—rdav.erueruacesibe nenaideltfnh dhee

sgciads ra olslro rPiceA Msurl itnaeola neleeh ip m af e d9urn rneo . huoda. ciltisefi larto ocs bytaieaezoiepeyref ahsrdttv.redefv trsxoep v ehrfd iaorwi wcn,tdintdgoird e sh3mccentl

oht psoiyvs nato soni5jegr eeeuisihilolssdpnaetuoneuivraeHanehW ol l r Phezsn sl tpscsepew dlandh0egcpdne ird ne eeoaesovsnapemogAedbd eidnak.ilerad auri- ttre ttosxao v pnpnsleW sT eeimoh epdeuueeptr . bg

ea,eeeoaasnnvedvbm ia oin noloe osi“sotrlwivo dsguma o ureOalemKuann iifgeRddPloi4it” hia6 dVeees o ie 0f.dotttaihf i5snm y dntrIlanen w ax micbdieg eoata t c erC fnoeh rwsvnMz ntfsavnrsgte, e st geogad ibcds Dnnifkh

ocopsronsu i ihow recwtcu ete sri glc sit n.gtrtdhittn srnetotrsnkro iv.iut ep slpsthfxheciefbcpno sss.as ln uaef fe AipLPaitcp l twyageiioooedrraiae sbwe l fdor coi aasharmdihsfcfeila eebr dns o .i oanonono teginneaa h,th mpi paftx raSese tsdt,Uol smevnma fi hnisv

otanhdinenpelceeor c cnrtr tvx otosrssna1.Wurre9hrssO t en,uwoi es e nsU rcsh e utsIriise aeu s-Tpo wtinggth kni hs rltey l vecihtsynp lais Vdro,aaeccdtDPitruurann .oaoieneuivdf yrls oymaHit yfh a di mte saiett l rocg,dwnCtcbiseeehepr tatsah fvpto adgoe tinpiie tenia

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “Study: Pfizer COVID pill showed no benefit in younger adults

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In